Get Full Government Meeting Transcripts, Videos, & Alerts Forever!
Get email alerts on the Sb46 Telemedicine topic
No spam. Unsubscribe anytime.
Senate rejects bill to require in-person exams for certain online prescriptions
Summary
SB 46, a bill to require a face-to-face patient-practitioner exam before prescribing certain medications over the internet, failed on the Senate floor after extended debate over safety, regulatory findings and whether state law or DOPL should govern telemedicine standards.
Senate Bill 46, aimed at clarifying the bona fide patient-practitioner relationship and requiring in-person exams before prescribing particular medications via internet questionnaires, failed to pass the Utah Senate on Feb. 24 after a protracted floor debate.
Sponsor Senator Knudson said the bill is designed to protect patient safety by ensuring a clinician determines whether a patient is at elevated cardiovascular risk before prescribing drugs that can interact with nitrates and drop blood pressure dangerously. "Prescribing [these drugs] without an in-person examination deprives millions of patients of proper medical diagnosis and treatment for these life-threatening conditions," he said on the floor.
Opponents noted an earlier panel review (February 2002) convened by the Division of Professional Licensing (DOPL) found that, in some configurations, online prescribing systems with adequate clinical safeguards could operate within Utah's practice standards. Senator Thomas read from the consent record of that panel and said he was troubled by the blanket in-person requirement given that the panel and a contracted physician had previously concluded some on-line evaluation models could be appropriate.
Senators also debated whether legislative intervention was appropriate when the regulatory division (DOPL) and medical panels have authority to regulate professional practice. Supporters pointed to changes in the pharmacy practice act since 2002 and the growing body of clinical evidence showing patient safety risks; some noted ongoing University of Utah research into internet medicine. Ultimately the Senate recorded 12 yes votes, 16 no votes and one absence, and the bill failed and will be filed.
What this means: The failure leaves existing regulatory processes in place for DOPL and other licensing bodies to shape telemedicine practice standards while signaling legislative concern about potential clinical risks in internet-only prescribing models. Sponsors said they will continue to engage regulators and monitor studies on telemedicine safety.
